| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |